Giving asthma meds at school could keep kids healthier and in class
NCT ID NCT03032744
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a program where children with asthma receive their daily preventive medication at school, along with education and check-ups. The goal was to reduce asthma symptoms, emergency visits, and missed school days. The study included 29 children enrolled in a school-based health center.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- asthma preventive medication (controller medication)
- What this could lead to
- If it works, this could show that giving daily asthma medication at school helps children have fewer symptoms and miss less school.
- What could go wrong
- This is a small, completed study with only 29 participants, so results may not apply to all children. The program requires school resources and may not be easy to expand.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
29 people
The number who actually took part.
- Started
-
Jan 2017
- Finished
-
Jun 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 to 14 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Active asthma * Diagnosed with asthma for at least 12 months * Enrolled in the school-based health center * Persistent asthma as defined by NAEPP-EPR3 guidelines OR at least 1 hospitalizations OR at least 2 ED/urgent care visits OR at least 2 courses of oral steroids for asthma in the previous 12 months for asthma Exclusion Criteria: * Underlying heart or lung disease other than asthma * Student has well controlled asthma
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
John R. Oishei Children's Hospital
Buffalo, New York, 14203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Asthma's hidden switch: scientists hunt for calcium channels in Kids' immune cells
- Can a simple breath test cut asthma Flare-Ups?
- Breathing tests face off: can extra lung measurements improve asthma diagnosis?
- The carbon label on your inhaler: can it sway a Doctor's choice?
- Six biologics put to the test in Real-World asthma and COPD care
- Can a digital program help teens with chronic illnesses move to adult care?